Acelyrin (SLRN) Company Overview

Profile

Full Name:

Acelyrin, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 4, 2023

Indexes:

Not included

Description:

SLRN, also known as Acelyrin, is a biopharmaceutical company focused on developing innovative treatments for autoimmune and inflammatory diseases. They aim to improve patient outcomes through advanced therapies, leveraging cutting-edge research and technology to address unmet medical needs in the healthcare market.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 7, 25 HC Wainwright & Co.
Neutral
Jan 7, 25 Citigroup
Neutral
Dec 11, 24 Wells Fargo
Overweight
Dec 11, 24 HC Wainwright & Co.
Neutral
Nov 14, 24 HC Wainwright & Co.
Neutral
Oct 16, 24 Wells Fargo
Overweight
Aug 19, 24 Morgan Stanley
Equal-Weight
Aug 15, 24 HC Wainwright & Co.
Neutral
Aug 14, 24 Piper Sandler
Overweight
Jul 8, 24 Wells Fargo
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Acelyrin?
  • Does Acelyrin pay dividends?
  • What sector is Acelyrin in?
  • What industry is Acelyrin in?
  • What country is Acelyrin based in?
  • When did Acelyrin go public?
  • Is Acelyrin in the S&P 500?
  • Is Acelyrin in the NASDAQ 100?
  • Is Acelyrin in the Dow Jones?
  • When was Acelyrin's last earnings report?
  • When does Acelyrin report earnings?
  • Should I buy Acelyrin stock now?

What is the ticker symbol for Acelyrin?

The ticker symbol for Acelyrin is NASDAQ:SLRN

Does Acelyrin pay dividends?

No, Acelyrin does not pay dividends

What sector is Acelyrin in?

Acelyrin is in the Healthcare sector

What industry is Acelyrin in?

Acelyrin is in the Biotechnology industry

What country is Acelyrin based in?

Acelyrin is headquartered in United States

When did Acelyrin go public?

Acelyrin's initial public offering (IPO) was on May 4, 2023

Is Acelyrin in the S&P 500?

No, Acelyrin is not included in the S&P 500 index

Is Acelyrin in the NASDAQ 100?

No, Acelyrin is not included in the NASDAQ 100 index

Is Acelyrin in the Dow Jones?

No, Acelyrin is not included in the Dow Jones index

When was Acelyrin's last earnings report?

Acelyrin's most recent earnings report was on Nov 13, 2024

When does Acelyrin report earnings?

The next expected earnings date for Acelyrin is Mar 28, 2025

Should I buy Acelyrin stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions